Development of binational radiation therapy quality indicator reports for prostate cancer treatment using registry data.
Edward ChmielMarie PaseMelanie EvansMaggie JohnsonJeremy L MillarNathan PapaPublished in: Journal of medical imaging and radiation oncology (2022)
QI reports for the treatment of prostate cancer by radiation oncologists have been produced using data from Australia and New Zealand patients. These are being disseminated to institutes on a six-monthly basis allowing comparisons to de-identified peers. The reports aim to facilitate improving patient outcomes, deepen engagement with the radiation oncology community and increase the breadth of PCOR-ANZ coverage. Additional QIs will be included in future iterations of these reports as data matures.
Keyphrases
- prostate cancer
- electronic health record
- adverse drug
- radiation therapy
- big data
- end stage renal disease
- ejection fraction
- newly diagnosed
- radical prostatectomy
- healthcare
- emergency department
- prognostic factors
- squamous cell carcinoma
- data analysis
- current status
- artificial intelligence
- deep learning
- advanced cancer